-
Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East
22 April 2024, Doha, Qatar – A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the…
Continue Reading..... -
First Arab Middle Eastern Genetics Research in Autism Going Global
Thanks to Qatar’s Sidra Medicine, we now have a better understanding of Middle Eastern Genetics and their Implications for ASD 1 April 2024, Doha, Qatar – On World Autism Awarene…
Continue Reading..... -
Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer
12 March 2024, Doha, Qatar – Sidra Medicine has appointed Mr. Wouter Van den Brande as its new Chief Operating Officer (COO). As COO of Sidra Medicine, Wouter's responsibilities will include overse…
Continue Reading..... -
Sidra Medicine Empowers Rare Disease Research
QF Entity opens accessibility to state-of-the-art research services 28 February 2024, Doha, Qatar – In support of Rare Disease Day, Sidra Medicine today announced the accessibility of its unique an…
Continue Reading.....